Clinical Trial Update: A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing glargine plus glulisine with premixed insulin in patients with type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glargine (insulin glargine)
• Premixed Insulin (insulin premix)
• glulisine (glulisine)

Snippet

Sponsor: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | Conditions: Type2 Diabetes | Phase 4 | Status: COMPLETED